摘要
目的观察性研究显示高密度脂蛋白胆固醇(HDL-C)具有心血管保护功能,但随机对照临床试验发现单纯升高HDL-C并未减少心血管病事件。可能的假设是不同的高密度脂蛋白颗粒(HDL-P)亚型与心血管病发生风险的关联不同。对HDL-P及其亚型与心血管病事件关系的前瞻性研究进行荟萃分析。方法数据来源MEDLINE、Cochrane图书馆和CNKI数据库,对相关参考文献进行核查。检索截止日期为2013年7月1日。纳入和排除标准:关于HDL-P亚型与心血管病事件关系的前瞻性研究。排除结果中未提供与HDL-P亚型相关的相对危险且未调整任何心血管病(CVD)危险因素的研究。数据提取与合并:2名作者独立进行资料提取和文献质量评价。进行异质性检验,计算合并效应指标相对风险(RR)及其95%可信区间。结果共6项研究入选。核磁共振方法可将HDL-P分为大、中、小三类。仅大HDL-P与CVD风险降低有关,RR为0.65(95%可信区间:0.55~0.76)。中HDL-P和小HDL-P则与CVD事件发生无关联。结论大HDL-P水平升高对CVD事件发生具有保护作用,对HDL-P亚型水平进行评估对于认识HDL的作用具有重要意义。
Objective High-density lipoprotein cholesterol (HDL-C) has cardio-protective effects. However, results from clinical trials showed that improving HDL-C levels alone did not reduce the cardiovascular disease (CVD) events and different HDL particles (HDL-P) subfractions may relate to different CVD risk. In this meta-analysis, we reviewed prospective studies reported relationships of HDL-P subfractions with CVD risk. Methods Data sources: MEDLINE, Coehrane Library and China National Knowledge Infrastructure (CNKI) were searched up to July 1st, 2013. Study selection: Prospective studies that reported an association of HDL-P subfractions with the incidence of CVD were included and studies did not assess the hazard ratio, relative risk, or odds ratio of HDL-P and studies did not adjust for any other risk factors were excluded. Data extraction and synthesis: All studies were extracted by 1 researcher and verified by another researcher. Full data were extracted from the studies meanwhile the quality was evaluated. Heterogeneity was analyzed. Pooled relative risk (RR) and 95% confidence interval were calculated. Results Six studies were enrolled in this meta-analysis. HDL-P can be grouped into three subfractions: large HDL-P, medium HDL-P and small HDL-P. Only higher large HDL-P concentration was associated with decreased risk for CVD and pooled RR was 0. 65 (95% CI:O. 55 -0. 76). Medium HDL-P and small HDL- P were not associated with the incidence of CVD events. Conclusion Higher large HDL-P concentration is associated with lower CVD risk. Assessment of HDL-P subfraetions may thus be of great clinical importance for evaluatin~ the CVD risk.
出处
《中华心血管病杂志》
CAS
CSCD
北大核心
2014年第1期57-61,共5页
Chinese Journal of Cardiology
基金
国家自然科学基金(81170266)